A
Adrienne Schippers
Researcher at University of Washington Medical Center
Publications - 4
Citations - 100
Adrienne Schippers is an academic researcher from University of Washington Medical Center. The author has contributed to research in topics: Vaccination & Coronavirus. The author has an hindex of 4, co-authored 4 publications receiving 45 citations.
Papers
More filters
Journal ArticleDOI
Variants of concern are overrepresented among post-vaccination breakthrough infections of SARS-CoV-2 in Washington State.
Abbye E McEwen,Seth M. Cohen,Chloe Bryson-Cahn,Catherine Liu,Steven A. Pergam,John B. Lynch,Adrienne Schippers,Kathy Strand,Estella Whimbey,Nandita S Mani,Allison J Zelikoff,Vanessa A. Makarewicz,Elizabeth R. Brown,Shah A Mohamed Bakhash,Noah R. Baker,Jared Castor,Robert J. Livingston,Meei-Li Huang,Keith R. Jerome,Keith R. Jerome,Alexander L. Greninger,Alexander L. Greninger,Pavitra Roychoudhury,Pavitra Roychoudhury +23 more
TL;DR: In this paper, the authors detected 20 vaccine breakthrough cases and all 20 (100%) infections were due to variants of concern (VOC) and had a median Ct of 20.2 (IQR=17.1-23.3).
Journal ArticleDOI
Low Prevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Among Pregnant and Postpartum Patients With Universal Screening in Seattle, Washington.
Sylvia M LaCourse,Alisa Kachikis,Michela Blain,LaVone E. Simmons,James A Mays,Amber D Pattison,Carol C Salerno,Stephen A. McCartney,Nicole M Kretzer,Rebecca Resnick,Rosemary Shay,Leah Savitsky,Anna Curtin,Emily M. Huebner,Kimberly K. Ma,Shani Delaney,Carlos Delgado,Adrienne Schippers,Jeff Munson,Paul S. Pottinger,Seth M. Cohen,Santiago Neme,Lori Bourassa,Andrew Bryan,Alexander L. Greninger,Keith R. Jerome,Keith R. Jerome,Alison C. Roxby,Erica M Lokken,Edith Cheng,Kristina M. Adams Waldorf,Kristina M. Adams Waldorf,Jane Hitti +32 more
TL;DR: Low prevalence of SARS-CoV-2 among pregnant and postpartum patients with universal testing is found and among asymptomatic patients, 2 were positive or inconclusive, respectively; repeat testing at 24 hours was negative.
Posted ContentDOI
Variants of concern are overrepresented among post-vaccination breakthrough infections of SARS-CoV-2 in Washington State
Abbye E McEwen,Seth M. Cohen,Chloe Bryson-Cahn,Catherine Liu,Steven A. Pergam,John B. Lynch,Adrienne Schippers,Kathy Strand,Estella Whimbey,Nandita S Mani,Allison J Zellikoff,Vanessa A. Makarewicz,Elizabeth R. Brown,Shah A Mohamed Bakhash,Noah R. Baker,Jared Castor,Robert J. Livingston,Meei-Li Huang,Keith R. Jerome,Keith R. Jerome,Alexander L. Greninger,Alexander L. Greninger,Pavitra Roychoudhury,Pavitra Roychoudhury +23 more
TL;DR: In this paper, the authors detected 20 vaccine breakthrough cases and all 20 (100%) infections were due to variants of concern (VOC) and had a median Ct of 20.2 (IQR=17.1-23.3).
Posted ContentDOI
Anti-SARS-CoV-2 antibody levels are concordant across multiple platforms but are not fully predictive of sterilizing immunity
Ben T Bradley,Andrew Bryan,Susan L Fink,Erin A. Goecker,Pavitra Roychoudhury,Meei-Li Huang,Haiying Zhu,Anu Chaudhary,Bhanupriya Madarampalli,Joyce Y-C Lu,Kathy Strand,Estella Whimbey,Chloe Bryson-Cahn,Adrienne Schippers,Nandita S Mani,Gregory Pepper,Keith R. Jerome,Keith R. Jerome,Chihiro Morishima,Robert W. Coombs,Mark H. Wener,Seth A Cohen,Alexander L. Greninger,Alexander L. Greninger +23 more
TL;DR: In this paper, the performance characteristics of the recently FDA authorized semi-quantitative anti-spike AdviseDx SARS-CoV-2 IgG II assay compared to the FDA authorized anti-nucleocapsid Abbott Architect SARS CoV2 IgG, Roche elecsys Anti-SARS-coV-1-2-S, EuroImmun anti-Sars-cov-2 ELISA, and GenScript surrogate virus neutralization assays and examined the humoral response associated with vaccination.